Fundraising FoxPrasetia Dwidharma — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
CB Therapeuticscbthera.cominSeed · Jul 2016
CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
Sher Butt(CEO)inJacob Vogan(Founder)inJason (Zhen) Qi(Founder)inGuoliang Yu(Executive Officer, Director)Stephanie Elliot(Admin)Thanos Karavokiris(Vice President Operations)
Co-investorsaVentureC3 VenturesJames Beshara FundMetaplanetPioneerY Combinator+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.